benzyloxycarbonylvalyl-alanyl-aspartyl-fluoromethyl-ketone has been researched along with Leukemia-P388* in 1 studies
1 other study(ies) available for benzyloxycarbonylvalyl-alanyl-aspartyl-fluoromethyl-ketone and Leukemia-P388
Article | Year |
---|---|
Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction.
Female sterility resulting from oocyte destruction is an unfortunate, and in many cases inevitable, consequence of chemotherapy. We show that unfertilized mouse oocytes exposed to therapeutic levels of the antitumor drug, doxorubicin (DXR), undergo apoptosis; however, fertilized oocytes do not initiate apoptosis, but enter cell-cycle arrest, when treated with DXR. Apoptosis induced by DXR in oocytes is blocked by sphingosine-1-phosphate, an inhibitor of ceramide-promoted cell death. Oocytes from Bax-deficient, but not p53-null, female mice display complete resistance to DXR-induced apoptosis in vivo and in vitro. Pretreatment of oocytes with a specific peptide inhibitor of caspases also abrogates the apoptotic response to DXR. These findings indicate that oocyte destruction caused by chemotherapy can be prevented by manipulation of apoptosis-associated signaling pathways. Topics: Amino Acid Chloromethyl Ketones; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Ceramides; Culture Techniques; Cysteine Proteinase Inhibitors; Doxorubicin; Female; Leukemia P388; Lysophospholipids; Mice; Oocytes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sphingosine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |